Atlas Trials

Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

Clinical trial NCT00183248 · COMPLETED

Trial details

NCT number
NCT00183248
Sponsor
University of Miami
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Kidney TransplantationKidney DiseaseKidney Failure
Start date
2004-09-01
Primary completion
2009-11-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.